prednisone has been researched along with Methemoglobinemia in 4 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This report describes a case of methemoglobinemia in association with dapsone therapy." | 7.73 | Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura. ( Roberts, WD; Schiff, DE; Sue, YJ, 2006) |
| "The authors report 8 cases of Horton's disease and/or polymyalgia rheumatica treated with prednisone with an initially favourable result." | 7.67 | [Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica]. ( Celton, H; Doury, P; Eulry, F; Fabresse, FX; Larroque, P; Pattin, S, 1984) |
| "This report describes a case of methemoglobinemia in association with dapsone therapy." | 3.73 | Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura. ( Roberts, WD; Schiff, DE; Sue, YJ, 2006) |
| "The authors report 8 cases of Horton's disease and/or polymyalgia rheumatica treated with prednisone with an initially favourable result." | 3.67 | [Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica]. ( Celton, H; Doury, P; Eulry, F; Fabresse, FX; Larroque, P; Pattin, S, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spoon, KC | 1 |
| Ramar, K | 1 |
| Schiff, DE | 1 |
| Roberts, WD | 1 |
| Sue, YJ | 1 |
| Doury, P | 1 |
| Fabresse, FX | 1 |
| Pattin, S | 1 |
| Eulry, F | 1 |
| Celton, H | 1 |
| Larroque, P | 1 |
| Norton, JM | 1 |
| Smith, RP | 1 |
1 review available for prednisone and Methemoglobinemia
| Article | Year |
|---|---|
Drugs acting on hemoglobin and the oxygen transport system.
Topics: Androgens; Anesthetics; Animals; Biological Transport; Carboxyhemoglobin; Cats; Cobalt; Cyanates; Do | 1976 |
3 other studies available for prednisone and Methemoglobinemia
| Article | Year |
|---|---|
Unexplained hypoxemia.
Topics: Ascorbic Acid; Azathioprine; Blood Gas Analysis; Dapsone; Female; Follow-Up Studies; Humans; Hyperca | 2011 |
Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Mur | 2006 |
[Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica].
Topics: Aged; Anemia, Hemolytic; Dapsone; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Iatrogeni | 1984 |